Eating disorder and self-harm diagnosis surged during the COVID-19 pandemic: an urgent need for intervention

FHS
June 23, 2023
8:11 am

Researchers examined incidence rates of eating disorders and self-harm after the COVID-19 pandemic.

Japan approves BMS’ Abecma for multiple myeloma treatment

Share this article Bristol-Myers Squibb’s Abecma is a BCMA-directed chimeric antigen receptor T cell immunotherapy. Credit: Dennis Diatel / Shutterstock.com. Japan has granted manufacturing and

December 7, 2023

Intuitive’s Q3 sales miss estimates as robot leasing, China demand weigh

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. By the numbers Q3 revenue: $1.74 billion

October 20, 2023

Fourth COVID-19 booster supercharges antibody defense in older adults, study says

The study finds that the fourth dose of the COVID-19 mRNA vaccine significantly boosts neutralizing antibody levels in the elderly, providing enhanced protection against new

August 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.